IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030
- PMID: 22079683
- DOI: 10.1016/j.diabres.2011.10.029
IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030
Abstract
Introduction: Diabetes is an increasingly important condition globally and robust estimates of its prevalence are required for allocating resources.
Methods: Data sources from 1980 to April 2011 were sought and characterised. The Analytic Hierarchy Process (AHP) was used to select the most appropriate study or studies for each country, and estimates for countries without data were modelled. A logistic regression model was used to generate smoothed age-specific estimates which were applied to UN population estimates for 2011.
Results: A total of 565 data sources were reviewed, of which 170 sources from 110 countries were selected. In 2011 there are 366 million people with diabetes, and this is expected to rise to 552 million by 2030. Most people with diabetes live in low- and middle-income countries, and these countries will also see the greatest increase over the next 19 years.
Discussion: This paper builds on previous IDF estimates and shows that the global diabetes epidemic continues to grow. Recent studies show that previous estimates have been very conservative. The new IDF estimates use a simple and transparent approach and are consistent with recent estimates from the Global Burden of Disease study. IDF estimates will be updated annually.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
The International Diabetes Federation diabetes atlas methodology for estimating global and national prevalence of diabetes in adults.Diabetes Res Clin Pract. 2011 Dec;94(3):322-32. doi: 10.1016/j.diabres.2011.10.040. Epub 2011 Nov 17. Diabetes Res Clin Pract. 2011. PMID: 22100977
-
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.Diabetes Res Clin Pract. 2017 Jun;128:40-50. doi: 10.1016/j.diabres.2017.03.024. Epub 2017 Mar 31. Diabetes Res Clin Pract. 2017. PMID: 28437734
-
Global estimates of diabetes prevalence for 2013 and projections for 2035.Diabetes Res Clin Pract. 2014 Feb;103(2):137-49. doi: 10.1016/j.diabres.2013.11.002. Epub 2013 Dec 1. Diabetes Res Clin Pract. 2014. PMID: 24630390
-
Projecting the impact of AIDS on mortality.AIDS. 1998;12 Suppl 1:S29-39. AIDS. 1998. PMID: 9677187 Review.
-
[Socioeconomic aspects of human immunodeficiency virus (HIV) infection in developing countries].Bull Acad Natl Med. 1990 Nov;174(8):1209-19; discussion 1219-21. Bull Acad Natl Med. 1990. PMID: 2094555 Review. French.
Cited by
-
Antihyperglycemic effect of Ginkgo biloba extract in streptozotocin-induced diabetes in rats.Biomed Res Int. 2013;2013:162724. doi: 10.1155/2013/162724. Epub 2012 Dec 20. Biomed Res Int. 2013. PMID: 23509685 Free PMC article.
-
Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis.PLoS One. 2012;7(12):e52036. doi: 10.1371/journal.pone.0052036. Epub 2012 Dec 28. PLoS One. 2012. PMID: 23300589 Free PMC article.
-
Potential effects of nichi glucan as a food supplement for diabetes mellitus and hyperlipidemia: preliminary findings from the study on three patients from India.Case Rep Med. 2012;2012:895370. doi: 10.1155/2012/895370. Epub 2012 Dec 10. Case Rep Med. 2012. PMID: 23304164 Free PMC article.
-
Fat- and fiber-related diet behavior among type 2 diabetes patients from distinct regions.Patient Prefer Adherence. 2015 Feb 19;9:319-25. doi: 10.2147/PPA.S71373. eCollection 2015. Patient Prefer Adherence. 2015. PMID: 25737634 Free PMC article.
-
Incidence of Depression and Associated Factors in Patients With Type 2 Diabetes in Quebec, Canada: A Population-Based Cohort Study.Medicine (Baltimore). 2016 May;95(21):e3514. doi: 10.1097/MD.0000000000003514. Medicine (Baltimore). 2016. PMID: 27227919 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous